<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00790309</url>
  </required_header>
  <id_info>
    <org_study_id>NNA-Early DM Resolution</org_study_id>
    <nct_id>NCT00790309</nct_id>
  </id_info>
  <brief_title>Early Diabetes Resolution After Weight Loss Surgery</brief_title>
  <official_title>Hormonal and Inflammatory Parameters Affecting Early Diabetes Resolution Following Weight Loss Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to compare inflammatory, hormonal, and metabolic changes in the very
      short term after various bariatric surgical procedures (Roux-en Y Gastric Bypass, Vertical
      Sleeve Gastrectomy, and Adjustable Gastric Banding)and other abdominal surgeries, as well as
      to compare these changes to diet-induced changes in the same population.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determine to what extent improvements in glycemic control can be attributed to caloric restriction after weight loss surgery</measure>
    <time_frame>10 days post-op</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determine changes in inflammatory markers after weight loss surgery</measure>
    <time_frame>10 days post-op</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">75</enrollment>
  <condition>Obesity</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Weight loss surgery</arm_group_label>
    <description>This group will be comprised of people having weight loss surgery: Roux-en Y gastric bypass, vertical sleeve gastrectomy, or adjustable gastric banding</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Abdominal surgery</arm_group_label>
    <description>This group will be comprised of people having abdominal surgeries such as nissen fundoplication or cholecystectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lean</arm_group_label>
    <description>This group will be comprised of normal weight healthy volunteers.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Weight loss surgery</intervention_name>
    <description>Weight loss surgery</description>
    <arm_group_label>Weight loss surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic abdominal surgeries</intervention_name>
    <description>laparoscopic abdominal surgeries</description>
    <arm_group_label>Abdominal surgery</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma and serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects scheduled for weight loss surgery or other abdominal surgeries will be considered
        for the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for surgery groups:

          -  BMI of 30 kg/m2 or higher

          -  Ages 18-65

          -  History of impaired glucose tolerance or T2DM

        Inclusion Criteria for normal weight group:

          -  BMI of 30 kg/m2 or lower

          -  Ages 18-65

        Exclusion Criteria:

          -  Development of an intercurrent infection

          -  Prior gastric, duodenal, proximal jejunal surgery or pancreas resection

          -  Current use of thiazolidinediones

          -  Current use of dipeptidyl peptidase-IV inhibitors (e.g., sitagliptin) or glucagon-like
             peptide-1 analogs (e.g., exenatide)

          -  Any condition felt by the PI or co-investigators to interfere with ability to complete
             the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naji Abumrad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2008</study_first_submitted>
  <study_first_submitted_qc>November 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2008</study_first_posted>
  <last_update_submitted>April 20, 2017</last_update_submitted>
  <last_update_submitted_qc>April 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Naji Abumrad</investigator_full_name>
    <investigator_title>Chairman, Department of Surgery</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Bariatric surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

